CRL4-DCAF8L1 Regulates BRCA1 and BARD1 Protein Stability
Authors:
Open Access
- 1 January 2022
- journal article
- research article
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 18 (4) , 1434-1450
Abstract
BRCA1 is frequently down-regulated in breast cancer, the underlying mechanism is unclear. Here we identified DCAF8L1, an X-linked gene product, as a DDB1-Cullin associated Factor (DCAF) for CUL4 E3 ligases to target BRCA1 and BARD1 for proteasomal degradation. Forced expression of DCAF8L1 caused reduction of BRCA1 and BARD1, and impaired DNA damage repair function, conferring increased sensitivity to irradiation and DNA damaging agents, as well as Olaparib, a PARPi anticancer drug; while depletion of DCAF8L1 restored BRCA1 and suppressed the growth of its xenograft tumors. Furthermore, the expression of DCAF8L1 was induced in human H9 ES cells during transition from primed to naïve state when Xi chromosome was reactivated. Aberrant expression of DCAF8L1 was observed in human breast fibroadenoma and breast cancer. These findings suggest that CRL4DCAF8L1 is an important E3 ligase that may participate in the development of breast cancer, probably through regulating the stability of BRCA1 and BARD1 tumor suppressor, linking BRCA1 and X chromosome inactivation to breast carcinogenesis.Keywords
This publication has 48 references indexed in Scilit:
- The F-box Protein FBXO44 Mediates BRCA1 Ubiquitination and DegradationJournal of Biological Chemistry, 2012
- Pathogenic Role of the CRL4 Ubiquitin Ligase in Human DiseaseFrontiers in Oncology, 2012
- Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cellsProceedings of the National Academy of Sciences, 2011
- Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genesBreast Cancer Research, 2009
- CRL4s: the CUL4-RING E3 ubiquitin ligasesTrends in Biochemical Sciences, 2009
- High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugsProceedings of the National Academy of Sciences, 2008
- BRCA1 regulates human mammary stem/progenitor cell fateProceedings of the National Academy of Sciences, 2008
- Male breast cancerThe Lancet, 2006
- X-inactivation profile reveals extensive variability in X-linked gene expression in femalesNature, 2005
- Loss of Bard1, the Heterodimeric Partner of the Brca1 Tumor Suppressor, Results in Early Embryonic Lethality and Chromosomal InstabilityMolecular and Cellular Biology, 2003